MMIT Network

The healthcare landscape is always evolving, but MMIT’s mission stays the same: We’re dedicated to helping clients solve their market access challenges. Learn more: ow.ly/BcC150Vl0vp

Not all market access partners are built the same. vist.ly/4vjvu Some provide information. MMIT provides context, continuity, and clarity — purpose‑built for pharma teams who need insight they can actually act on. Download this infographic to see what MMIT delivers that others don’t.

Free-text plan names are like junk drawers. You can dig through them… but wouldn’t you rather know exactly what’s inside? With MMIT’s BIN/PCN/Group mapping, you gain structure, clarity, and confidence in coverage insights. Meet with MMIT to learn more. Because guessing isn’t a strategy. vist.ly/4vfxp

vist.ly/4vf7i | Determining whether a therapy is covered shouldn't be a matter of guesswork. In this infographic, see how both pharma and HIT companies can leverage BIN/PCN/Group data to pinpoint coverage with precision—down to the formulary and restriction level.

Congratulations to the finalists for the 2026 Patient Choice Awards! We are proud to honor these specialty pharmacies for going the extra mile to provide excellent patient service. The finalists are calculated based on the highest average net promoter scores (NPS) from quarterly Specialty Pharmacy Patient Satisfaction surveys throughout 2025. Hospital & Health System Specialty Pharmacy: • Arnot Health Specialty Pharmacy • Prisma Health Specialty Pharmacy (@theprismahealth) • Towers Specialty Pharmacy (@eBHC) Independent Specialty Pharmacy: • FountainRx Specialty Pharmacy • Onco360 Oncology Pharmacy • PANTHERx® Rare Pharmacy Infusion Specialty Pharmacy: • 1st Option Home Infusion Pharmacy (@1stOptionHome) • Coram CVS Specialty Infusion Services (@CVSHealth) • CSI Pharmacy Payer/PBM Specialty Pharmacy: • CenterWell Specialty Pharmacy® • CVS Specialty® • Lumicera Health Services Retail Specialty Pharmacy: • BioPlus Specialty Pharmacy (formerly Kroger Specialty Pharmacy) •.Walgreens Specialty Pharmacy • Walmart Specialty Pharmacy Specialty Pharmacy Hubs: • AcariaHealth Specialty Pharmacy • RareMed Solutions (@Rare_Med)

vist.ly/4v8sy | Unstructured data holds untapped value. We make it usable. MMIT and its parent company, Norstella, convert clinical notes and EMR narratives into structured, connected insights. The result is a clearer view of the patient journey and the ability to act on it. See how we do it.

The future of market access won’t hinge on more data. Clarity matters most. In this video, we show how MMIT brings together policy data, real‑world data, AI, and human expertise to reveal what’s really happening from policy intent to patient access. If you’re ready to see the full picture, this one’s for you. 🎥 See the real market access picture: vist.ly/4v74p

More clarity. More context. More confidence. Asembia 2026 is coming, and MMIT is bringing so much more than market access data. Catch us April 27–30 at Booth 1415 in Las Vegas. Reserve your spot today: vist.ly/4u2sn

vist.ly/4uynj | Accurately identify patients and their HCPs, even for rare and hard-to-diagnose conditions. MMIT’s HCP and Patient Targeting Solution is powered by NorstellaLinQ, the industry’s first fully integrated data asset. By combining structured and unstructured data, we help you pinpoint the right patients and the providers who treat them. Learn how precision targeting yields more effective results.

vist.ly/4ujfx | Get closer to the patient than ever before. MMIT, powered by NorstellaLinQ, delivers pharma’s first fully linked and integrated data asset. With unmatched access to open and closed claims, lab results, EMRs, and coverage data, we help you build smarter, faster market access strategies. Learn more at the link in this post.

vist.ly/4uiem | The FTC says Optum Rx and Caremark are in talks to settle the same lawsuit that led Express Scripts to agree to end the practice of preferring more expensive drugs on formularies. Will other PBMs agree to similar reforms? Find out with MMIT’s industry‑leading payer panel. To support your understanding of market shifts like these, MMIT’s Rapid Family is a suite of solutions designed to deliver timely, actionable insights. By leveraging our expert team and industry‑leading panel, you gain fast access to the answers you need to stay ahead of market changes. Learn more at the link in this post.

Free-text plan names are like junk drawers. You can dig through them… but wouldn’t you rather know exactly what’s inside? With MMIT’s BIN/PCN/Group mapping, you gain structure, clarity, and confidence in coverage insights. Meet with MMIT to learn more. Because guessing isn’t a strategy. vist.ly/4ueee

You can track what payers say. You can monitor what prescribers do. But do you see what happens in between? Watch this video to see how MMIT connects data, AI‑powered insights, and human intelligence to help teams see the real picture in market access—and make more confident decisions. 👉 Turn data into clarity with MMIT: vist.ly/4ubiw

vist.ly/4u82d | Employee Spotlight! Team lead and senior access advisor Jacquie Eckrote enjoys helping pharma help companies understand how payer policies impact their therapies.

Is your message breaking through or getting lost in the noise? vist.ly/4u4bi MMIT’s Message Monitor gives you a “fly-on-the-wall” view into real conversations between payers, HCPs, and IDNs, so you can see exactly how your message resonates, where it stands against competitors, and what decision-makers really think. Now’s the time to fine-tune your story and strengthen your strategy before new coverage and formulary updates roll out. Schedule a demo to gain insights into payer and IDN brand perception.

Coverage shouldn’t feel like detective work. 🕵️ By standardizing BIN/PCN/Group data with MMIT, teams can reduce guesswork and focus on what actually matters: patient access and informed decisions. Illuminate your path with MMIT today. vist.ly/4t24a

Unstructured data has become one of the most valuable assets for market access teams—and machine learning and natural language processing are the key to unlocking it. vist.ly/4tph2 Discover six real examples of how organizations are using these technologies to inform targeting, improve access, and strengthen commercialization strategies. Read now to uncover actionable insights

Employee Spotlight! Meet Jacquie Eckrote, senior access advisor and competitive horseback rider. Jacquie helps clients interpret payer policy data and determine next steps to overcome any hurdles that impede patient access. vist.ly/4t54a

One of the biggest launch mistakes we see is waiting too long to engage payers. By the time restrictive policies are in place, leverage is already lost. MMIT’s Jason Rodman and Carolyn Zele run through the most common risks and how to fix them before it’s too late. vist.ly/4sytm

In the Medicare space, many manufacturers are now offering rebates on products that have never been under contract before. vist.ly/4sy3d In this blog, MMIT’s @sudhanshuSahu looks at what payers have learned since their initial response to the Inflation Reduction Act.

Understanding the patient journey is getting more complex. Machine learning and natural language processing are helping make it clearer. vist.ly/4stin In our latest ebook, we’re sharing real stories about how MMIT and NorstellaLinQ help pharma manufacturers understand the patient journey quicker and improve market access strategies. Read now to see how ML and NLP clarify the patient journey.